ABOUT HEMGENIX

Amount of qualified sufferers: CDEC talked over the uncertainty in the volume of patients with reasonably significant to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical industry experts consulted by CADTH indicated that some people that are labeled as obtaining gentle or average condition could have a significant blee